1.31 USD
↘ 0.06 (4.38%)AT CLOSE (11:59 AM EDT)
Geron Corp
GERNNASDAQ • USD
1.31
↘ 0.01 (0.38%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
1.31
↘ 0.01 (0.38%)
Market: CLOSED
Geron Corp (GERN) trades at $1.31 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Strong Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place GERN at a fair price relative to peers.
Technical & fundamental data as of Sep 15, 2026.
Open?$1.37
High?$1.37
Low?$1.30
Prev. Close?$1.37
Volume?16.5M
Avg. Volume?11.1M
VWAP?$1.32
Rel. Volume?1.49x
Bid / Ask
Bid?$1.12 × 100
Ask?$1.34 × 2.0K
Spread?$0.22
Midpoint?$1.23
Valuation & Ratios
Market Cap?880.2M
Shares Out?642.5M
Float?626.7M
Float %?97.6%
P/E Ratio?N/A
P/B Ratio?4.03
EPS?-$0.11
Dividend?0.00%
Ex-Dividend?N/A
RelatedALKS
News
Profile
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.
Themes
Address
919 EAST HILLSDALE BOULEVARD
FOSTER CITY, CA 94404
Phone: (650) 473-7700
FOSTER CITY, CA 94404
Phone: (650) 473-7700
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?20
Short Sent.?43
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.28Distress
Confidence?65%Moderate
Short InterestVery High
Short % of Float?13.58%High
Short Interest?85.1M
Days to Cover?11.0
Free Float626.7M
Avg Daily Volume7.7M
Settlement Date2026-08-31
Financial Health
Current Ratio?6.92Strong
Quick Ratio?5.16Strong
Cash Ratio?0.89Adequate
Debt/Equity?1.14Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?4.03FAIR▾
Peers100
S&P44
P/S?4.30FAIR▾
Peers100
S&P35
P/FCF?N/A▾
EV/EBITDA?-30.7CHEAP▾
Peers100
S&P97
EV/Sales?5.22FAIR▾
Peers50
S&P34
Returns & Efficiency
ROE?-30.9%WEAK▾
Peers50
S&P6
ROA?-13.0%WEAK▾
Peers50
S&P3
Cash Flow & Enterprise
FCF?$-114762000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day